Optimind Pharma Corp. (OMND.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 02/28
(Values in thousands)
| 02-2025 | 02-2024 | 02-2023 | 02-2022 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 84 | 29 | 552 | 1,352 |
| Receivables | 66 | 159 | 116 | 2 |
| Other current assets | 0 | 0 | 0 | 506 |
| TOTAL | $150 | $188 | $668 | $1,861 |
| Non-Current Assets | ||||
| PPE Net | N/A | 0 | 95 | 125 |
| Investments And Advances | 50 | 50 | 50 | 310 |
| Intangibles | N/A | 0 | 371 | 1,521 |
| Other Non-Current Assets | 0 | 0 | 171 | 0 |
| TOTAL | $50 | $50 | $687 | $1,956 |
| Total Assets | $200 | $238 | $1,354 | $3,816 |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | 126 | 126 | 504 | N/A |
| Accounts payable and accrued liabilities | N/A | 242 | 92 | 132 |
| Other current liabilities | N/A | N/A | N/A | 506 |
| TOTAL | $275 | $367 | $625 | $664 |
| Non-Current Liabilities | ||||
| TOTAL | $0 | $0 | $90 | $113 |
| Total Liabilities | $275 | $367 | $715 | $776 |
| Shareholders' Equity | ||||
| Common Shares | 4,793 | 4,523 | 4,025 | 3,387 |
| Retained earnings | -5,039 | -4,823 | -3,425 | -347 |
| Other shareholders' equity | 162 | 162 | 0 | 0 |
| TOTAL | $-75 | $-129 | $640 | $3,040 |
| Total Liabilities And Equity | $200 | $238 | $1,354 | $3,816 |